【摘 要】
:
AIM Silent information regulator 1 (Sirtl), a class ⅢI histone deacetylase, has been reported to attenuate myocardial and kidney ischemia-reperfusion(I-R) injury.However, the mechanisms of Sirtl in he
【机 构】
:
Dalian Medical University,Dalian,China
【出 处】
:
第二届世界天然药物和传统药物药理学学术会议
论文部分内容阅读
AIM Silent information regulator 1 (Sirtl), a class ⅢI histone deacetylase, has been reported to attenuate myocardial and kidney ischemia-reperfusion(I-R) injury.However, the mechanisms of Sirtl in hepatic I-R have not been elucidated.Carnosic acid (CA), a rosemary phenolic compound, was demonstrated to protect the brain against oxidative stress during middle cerebral artery I-R.The present study was performed to determine CA would reduce hepatic I-R stress and to clarify the molecular mechanisms of CA.METHODS In vivo, rats were randomly exposed to sham-operated group, I-R group (45 rain ischemia to 70% of the liver followed by 90 rain reperfusion), CA (60 mg·kg-1, given 60 rain before surgery), I-R + CA, ischemic preconditioning (IPC).After reperfusion,pathological alterations, apoptosis index, serum aminotransferases and inflammation factors were measured.The expressions of Sirtl,P66shc and NF-κB in hepatic were detected.In vitro, HepG2 cell was treated with CA 2.5, 5 and 10 μmol·L-1.After this treatment,the expression of Sirtl was measured.RESULTS In vivo, CA and IPC decreased I-R-mediated the sermn levels of aminotransferases,inflammatory response and hepatocellular damage.Hepatic I-R injury was associated with decreased Sial, increased P66ahc and upregulated NF-κB, which were prevented by CA and IPC.CA and IPC also significantly attenuated levels of I-R-induced hepatic cell apoptosis.In vitro, CA increased the Sirtl protein level in a dose and time-dependent manner.CONCLUSION For the first time, we confirm that CA can protect hepatic against inflammation and apeptosis caused by I-R through Sirtl pathway.These results reveal a new protective mechanism elicited by CA-induced SIRT1 activation in I-R tissues and suggest a novel potential therapeutic targets to manage 1-R-induced hepatic dysfunction.
其他文献
AIM To investigate the effects of curcumin on neonatal rat cardiac myocytes exposure to high-glucose and the mechanisms involved.METHODS Neonatal rat cardiomyocytes were cultured in normal-glucose (NG
AIM To study protective effects of scutellarin (SCU), a flavonoid from a traditional Chinese medicinal plant, on brain damage in rats after ischemia-reperfusion (I-R) injury, and to investigate differ
AIM Protective effects of scutellarin (SCU) on myocardial ischemia reperfusion (I-R) in rats was evaluated, different SCU treatments were compared and SCUs effect-time relationship was also investigat
AIM To investigate the effects of Heijiangdan Ointment on regulating oxidative stress in 60Co γ-ray radiation injured dermatitis tissue in mice.METHODS Female Wistar mice with 4 grade radiation dermat
AIM To observe the influence of Mongolian traditional medicine DAGEBU-15 (MD-15) to the contraction effects of isolated intestinal smooth muscle of rat caused by acetylcholine(ACh).METHODS Isolated in
AIM The relaxing effect of the extract from Schizophyllum commune (SC) on rat aorta as well as the underlying mechanisms were investigated.METHODS Dried SC was extracted with 50%, 90% ethanol or deion
AIM Ciwujia is a traditional herb that has been widely used in China, and also named Acanthopanax senticosus.It is an important Chinese folk medicine for the treatment of insomnia.In this study, the m
AIM To observe the reversal effects of Ganoderma lucidum polysaccharide (Gl-PS) on multidrug resistance (MDR)to K562/A in vitro and in vitro.To investigate the mechanism of MDR-reversal effect on Gl-P
AIM To screen the active components of the Yao minority folk medicine Melastoma dodecandrum Lour.in reducing blood glucose.METHODS Extracted with 95% ethanol, the drugs Melastoma dodecandrum Lour.were
AIM The present study was designed to obverse whether c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) regulates the angiogenesis of human umbilical vein endothelial cells (HUVEC) in